Surrey, United Kingdom

Simon Leppard

USPTO Granted Patents = 10 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 82(Granted Patents)


Location History:

  • Farnham, GB (2012 - 2013)
  • Surrey, GB (2008 - 2018)

Company Filing History:


Years Active: 2008-2018

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Simon Leppard

Introduction

Simon Leppard is a notable inventor based in Surrey, GB. He has made significant contributions to the field of medical technology, particularly in the area of chemoembolotherapy. With a total of 10 patents to his name, Leppard's work has the potential to impact cancer treatment significantly.

Latest Patents

One of Simon Leppard's latest patents involves a composition for chemoembolotherapy of solid tumors. This innovative composition comprises particles of a water-insoluble, water-swellable synthetic anionic polymer, with an anthracycline absorbed within. The polymer is suitably a poly(vinyl alcohol) based polymer, and the drug used in this composition is doxorubicin. This patent represents a significant advancement in targeted cancer therapies.

Career Highlights

Throughout his career, Simon Leppard has worked with prominent companies in the medical field. Notably, he has been associated with Biocompatibles UK Limited and Abbott Laboratories Corporation. His experience in these organizations has contributed to his expertise and innovative capabilities in developing medical solutions.

Collaborations

Simon Leppard has collaborated with several professionals in his field. Some of his notable coworkers include Andrew Lennard Lewis and Peter William Stratford. These collaborations have likely enriched his work and led to further advancements in his inventions.

Conclusion

Simon Leppard's contributions to medical technology, particularly in chemoembolotherapy, showcase his innovative spirit and dedication to improving cancer treatment. His patents and collaborations reflect a commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…